Tag: Atara

Cell and Gene Therapy, Industry

Bayer pulls plug on $670M CAR-T cell therapy pact with Atara in wake of patient death

May 20, 2022

Via: FierceBiotech

Bayer is pulling the plug on its $670 million CAR-T pact with Atara Biotherapeutics. Three months after a death paused a study of the lead candidate, the German drugmaker has decided to cut its ties to Atara‚Äôs two mesothelin-directed CAR-T […]